Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy
- PMID: 20164475
- DOI: 10.1056/NEJMp1001578
Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical